FDA Moves to Legalize Untested Peptides, Handing a $2.2B Market to Telehealth Companies on Preclinical Evidence

FDA Moves to Legalize Untested Peptides, Handing a $2.2B Market to Telehealth Companies on Preclinical Evidence | BedrockNews